UK Close to Closing Covid-19 Vaccine Deal With Sanofi and GSK for $624M

Sanofi (SNYNF) and GlaxoSmithKline (GSK) are close to clinching a £500 million ($624 million) deal to supply the UK with their COVID-19 vaccine
#vaccine #covid #investment #stocks https://t.co/SnSzJ97PGP https://t.co/fZmq4pDEhV